← Leaderboards
Omar O Abudayyeh
Harvard Medical School
$3,693,257
Attributed
$7,308,036
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,308,036 · 6
By mechanism
R01$6,452,381 · 3
R21$414,150 · 1
R56$363,027 · 1
F30$78,478 · 1
Top collaborators
- Jonathan Samuel Gootenberg14 shared
Most similar at Harvard Medical School
Same institution · by research overlap
- Sachin Patel$155,909
- Samuel Wattrus$517,776
Others in their field
Top investigators on “Engineering”
- David Heimbrook · Leidos Biomedical Research, Inc.$265,348,415
- Francis L Halzen · University Of Wisconsin-Madison$239,306,664
- Lisa Garcia Bedolla · University Of California-Berkeley$175,927,128
- Daniel Stanzione · Arizona State University$173,674,275
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$173,157,760
- Kiyoshi Suyehiro · Iodp Management International, Inc$166,539,344
Research focus
EngineeringGenesCellsBiologyCell TypeIn VivoScreeningModificationInsightClustered Regularly Interspaced Short Palindromic RepeatsProteinsBiochemicalNovel TherapeuticsComplexEnzymesTranscription FactorBioinformaticsBiomedical ResearchProtein EngineeringTechnologyDisease ModelRecruitBaseGenome Editing
Grant awards (16)
Discovery and manipulation of transcription factors to restore long term stem cell repopulation in aged bone-marrow$683,120
R01 · FY2025 · AG · contact PI
Developing programmable RNA writing tools with the novel RNA-guided RNA-targeting CRISPR effector Cas7-11$442,036
R01 · FY2025 · GM
Discovery and manipulation of transcription factors to restore long term stem cell repopulation in aged bone-marrow$716,812
R01 · FY2024 · AG · contact PI
Programmable gene integration and cell engineering with CRISPR-directed integrases$664,371
R01 · FY2024 · EB · contact PI
Developing programmable RNA writing tools with the novel RNA-guided RNA-targeting CRISPR effector Cas7-11$460,261
R01 · FY2024 · GM
Discovery and manipulation of transcription factors to restore long term stem cell repopulation in aged bone-marrow$611,230
R01 · FY2023 · AG · contact PI
Programmable gene integration and cell engineering with CRISPR-directed integrases$574,001
R01 · FY2023 · EB · contact PI
Developing programmable RNA writing tools with the novel RNA-guided RNA-targeting CRISPR effector Cas7-11$556,500
R01 · FY2023 · GM
Discovery and manipulation of transcription factors to restore long term stem cell repopulation in aged bone-marrow$601,926
R01 · FY2022 · AG · contact PI
Programmable gene integration and cell engineering with CRISPR-directed integrases$574,001
R01 · FY2022 · EB · contact PI
Programmable gene integration and cell engineering with CRISPR-directed integrases$568,123
R01 · FY2021 · EB · contact PI
RNA targeting tools with novel specific RNA-guided RNA-targeting CRISPR effectors$363,027
R56 · FY2021 · HG
Systematic discovery, characterization, and design of novel genome editing and delivery tools using a high-throughput metagenomic screening pipeline$225,900
R21 · FY2021 · AI
Systematic discovery, characterization, and design of novel genome editing and delivery tools using a high-throughput metagenomic screening pipeline$188,250
R21 · FY2020 · AI
Characterization of a novel RNA-guided endoRNAse and applications towards genome-wide screening for non-coding RNA roles in melanoma resistance$29,902
F30 · FY2018 · CA · contact PI
Characterization of a novel RNA-guided endoRNAse and applications towards genome-wide screening for non-coding RNA roles in melanoma resistance$48,576
F30 · FY2016 · CA · contact PI